HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Ibáñez, A. Articles by Martínez, M.-A. Search for Related Content PubMed PubMed Citation Articles by Ibáñez, A. Articles by Martínez, M.-A. Agricola Articles by Ibáñez, A. Articles by Martínez, M.-A.

Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies

Fundació irsiCaixa, Laboratori de Retrovirologia, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain¹

Author for correspondence: Miguel-Angel Martínez. Fax +34 93 4653968. e-mail mamartz{at}ns.hugtip.scs.es

The impact of emergence of genetic resistance, soon after the beginning of antiretroviral therapy, on the genotype of other viral loci not implicated in the development of resistance was studied in four human immunodeficiency type 1 (HIV-1)-infected patients subjected to indinavir monotherapy. Two patients were chosen because they showed no decrease in virus load during the study period and two were selected because they showed a rapid decline in plasma viraemia after the initiation of therapy and a virus rebound after 12 weeks of treatment. The evolution of virus sequences was analysed within the four infected patients by examining virus sequences spanning the protease and C2–V3 env genes by RT–PCR of plasma samples obtained at the beginning and after 12 weeks of therapy. PCR products from the two genomic regions from the two sample points per patient were cloned and 10–15 clones from each sample were sequenced. Genotypic indinavir resistance was present in the four patients after 12 weeks of therapy. The overall protease and C2–V3 env regions quasispecies diversity at time zero was higher than that after 12 weeks of therapy, but this difference was more significant in the two patients who showed a reduction in virus load soon after the initiation of treatment. C2–V3 env sequences indicated that changes during emergence of resistance to indinavir were only detected in the two patients who showed a drastic reduction in virus load. Thus, a temporal relationship was observed between the start of therapy, a drastic reduction in virus load and a drift in the HIV-1 env quasispecies.

This article has been cited by other articles:

				T. Nora, C. Charpentier, O. Tenaillon, C. Hoede, F. Clavel, and A. J. Hance Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment J. Virol., July 15, 2007; 81(14): 7620 - 7628. [Abstract] [Full Text] [PDF]

				G. Fernandez, B. Clotet, and M. A. Martinez Fitness Landscape of Human Immunodeficiency Virus Type 1 Protease Quasispecies J. Virol., March 1, 2007; 81(5): 2485 - 2496. [Abstract] [Full Text] [PDF]

				C. Charpentier, T. Nora, O. Tenaillon, F. Clavel, and A. J. Hance Extensive Recombination among Human Immunodeficiency Virus Type 1 Quasispecies Makes an Important Contribution to Viral Diversity in Individual Patients J. Virol., March 1, 2006; 80(5): 2472 - 2482. [Abstract] [Full Text] [PDF]

				K. M. Kitrinos, J. A. E. Nelson, W. Resch, and R. Swanstrom Effect of a Protease Inhibitor-Induced Genetic Bottleneck on Human Immunodeficiency Virus Type 1 env Gene Populations J. Virol., August 15, 2005; 79(16): 10627 - 10637. [Abstract] [Full Text] [PDF]

				R. M. Troyer, K. R. Collins, A. Abraha, E. Fraundorf, D. M. Moore, R. W. Krizan, Z. Toossi, R. L. Colebunders, M. A. Jensen, J. I. Mullins, et al. Changes in Human Immunodeficiency Virus Type 1 Fitness and Genetic Diversity during Disease Progression J. Virol., July 15, 2005; 79(14): 9006 - 9018. [Abstract] [Full Text] [PDF]

				H. Li and M. J. Roossinck Genetic Bottlenecks Reduce Population Variation in an Experimental RNA Virus Population J. Virol., October 1, 2004; 78(19): 10582 - 10587. [Abstract] [Full Text] [PDF]

				M. Magierowska, F. Bernardin, S. Garg, S. Staprans, M. D. Miller, K. K. A. Van Rompay, and E. L. Delwart Highly Uneven Distribution of Tenofovir-Selected Simian Immunodeficiency Virus in Different Anatomical Sites of Rhesus Macaques J. Virol., March 1, 2004; 78(5): 2434 - 2444. [Abstract] [Full Text] [PDF]

				L. Doukhan and E. Delwart Population Genetic Analysis of the Protease Locus of Human Immunodeficiency Virus Type 1 Quasispecies Undergoing Drug Selection, Using a Denaturing Gradient-Heteroduplex Tracking Assay J. Virol., July 15, 2001; 75(14): 6729 - 6736. [Abstract] [Full Text]